VEGF imaging for early breast cancer detection.

VEGF imaging for early breast cancer detection. - VEGF imaging for early breast cancer detection.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35509

Enrollment

Registered

2009-10-05

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer cancer of the breast

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a breast tumor who are scheduled to receive operative intervention either by means of a mastectomy or lumpectomy

Exclusion criteria

Exclusion criteria: • Other invasive malignancy or condition which could affect compliance with the protocol or interpretation of results. • Pregnant or lactating women. • Prior radiotherapy on the involved area. • Major surgery within 28 days before the initiation of the study. • Clinically significant cardiovascular disease. • Prior allergic reaction to immunoglobulins or immunoglobulin allergy.

Design outcomes

Primary

Measure	Time frame
The primary endpoint will be 89Zr-bevacizumab tracer uptake in primary breast tumors	—

Secondary

Measure	Time frame
The secondary endpoint will be 89Zr-bevacizumab tracer uptake in axillary lymph nodes.	—

Countries

Netherlands

Outcome results